- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03146026
The Effects of a Combined Exercise Training Program on Vascular Health and Metabolic Profile in Obese Adolescent Girls.
October 30, 2020 updated by: Won-mok son, Pusan National University
The Effects of a 12- Week Combined Exercise Training Program on Arterial Stiffness, Endothelial Function, Inflammatory Markers and Metabolic Profile in Obese Adolescent Girls: A Pilot Study.
The purpose of this study was to examine the impact of 12 weeks of combined exercise training (CET) on arterial stiffness, endothelial function, inflammatory markers, insulin resistance, and body composition in obese adolescent girls.
Thirty obese adolescent girls participated in this study.
The girls were randomly divided into CET group (n=15) and control group (n=15).
The CET group performed concurrent resistance training followed by aerobic training at 40-70% of the heart rate reserves (HRR) 3 days/week for 12 weeks.
Plasma nitric oxide, endothelin-1, C-reactive protein, arterial stiffness, homeostasis model assessment of insulin resistance (HOMA-IR), glucose, insulin, and the adiponectin/leptin ratio were measured before and after the 12-weeks study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Obese with hyperinsulinemia
- Abdominal obesity
- Sedentary (no regular exercise training or physical activity)
- No weight loss diet during last 6 months.
Exclusion Criteria:
- Hypertension
- Pregnancy
- Chronic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No Exercise (CON)
Fifteen obese adolescent girls.
This arm did not perform any exercise training for 12 weeks.
Caloric intake was 1921.7 kcal/day.
|
|
|
Experimental: Combined Exercise Training (CET)
Fifteen obese adolescent girls.
This arm performed combined exercise training 3 times per a week for 12 weeks.
Caloric intake was 1921.7 kcal/day.
|
The CET program was performed for 60 minutes with 5 minutes of warm-up and cool-down per day, 3 times a week for 12 weeks.
Combined exercise consisted of 20 minutes of various resistant band exercises (Upper body: seated rows, biceps curl, shoulder flexion, elbow flexion, chest press; Lower body: hip flexion, hip extension, calf raise, leg press, squat) and 30 minutes of treadmill walking.
The warm-up and cool down consisted of static stretching.
Intensity of exercise was gradually increased from 40-50% heart rate reserve (HRR) in weeks 1-4, and to 60-70% HRR in weeks 9-12.
Each training session was fully supervised by the researchers.
Every subject wore a heart rate monitor during the whole training session so as to maintain the correct training intensity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Endothelin-1
Time Frame: 12 weeks
|
Levels of Endothelin-1 in blood were measured by Endothelin-1 enzyme immunoassay kit.
|
12 weeks
|
|
Height
Time Frame: 12 weeks
|
Height was measured to nearest 1 cm.
|
12 weeks
|
|
Arterial stiffness
Time Frame: 12 weeks
|
Arterial stiffness was measured as measurement of baPWV (m/s).
|
12 weeks
|
|
Insulin resistance
Time Frame: 12 weeks
|
Insulin resistance was estimated using the homeostasis model assessment of insulin resistance (HOMA-IR).
|
12 weeks
|
|
Plasma leptin
Time Frame: 12 weeks
|
Plasma leptin was determined by ELISA kit
|
12 weeks
|
|
Plasma adiponectin
Time Frame: 12 weeks
|
Plasma adiponectin was measured using ELISA kit
|
12 weeks
|
|
Body weight
Time Frame: 12 weeks
|
Body weight was measured to nearest 0.1 kg.
|
12 weeks
|
|
Waist circumference
Time Frame: 12 weeks
|
Waist circumference was measured at midpoint between the lower rib and the iliac crest at the end of a normal expiration using a tape measure
|
12 weeks
|
|
Body fat
Time Frame: 12 weeks
|
Percent body fat (%) was determined using a bioelectrical impedance-meter.
|
12 weeks
|
|
Maximal heart rate
Time Frame: 12 weeks
|
Maximal heart rate was obtained at the end of a graded treadmill exercise test performed until volitional exhaustion.
|
12 weeks
|
|
Nitric oxide
Time Frame: 12 weeks
|
Nitric oxide generation was measured by Griess assay kit.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 8, 2010
Primary Completion (Actual)
May 2, 2011
Study Completion (Actual)
May 6, 2011
Study Registration Dates
First Submitted
May 5, 2017
First Submitted That Met QC Criteria
May 5, 2017
First Posted (Actual)
May 9, 2017
Study Record Updates
Last Update Posted (Actual)
November 3, 2020
Last Update Submitted That Met QC Criteria
October 30, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PusanNU-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Adolescent
-
National University of MalaysiaUniversiti Putra Malaysia; University of RoehamptonCompletedAdolescent Obesity | Adolescent Behavior | Adolescent OverweightMalaysia
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom
-
Delta University for Science and TechnologyCompletedObesity, Adolescent | Adolescent DevelopmentEgypt
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity, Adolescent | Adolescent Behavior
-
VIVUS LLCCompletedAdolescent Obesity | Obesity in Adolescence | Adolescent OverweightUnited States
-
Fondation Santé des Étudiants de FranceNot yet recruitingPediatric Obesity | Adolescent Obesity | Severe Adolescent Obesity
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; National Institutes of Health (NIH); National Center...CompletedAdolescent Obesity | Diet, Healthy | Adolescent OverweightUnited States
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingSleep | Adolescent Obesity | Dietary Intake | Adolescent Overweight | Eating BehaviorsUnited States
-
University of BedfordshireCompletedInsulin Resistance | Adolescent Obesity | Adolescent BehaviorUnited Kingdom
-
Cairo UniversityMansoura University; British University In Egypt; Prince Sattam Bin Abdulaziz... and other collaboratorsCompletedObesity | BMI | Health Promotion | Overweight Adolescents | Obesity Prevention | Behaviour Change | Overweight/Obesity, Adolescent | Health Behavior, RiskyEgypt
Clinical Trials on Combined Exercise Training
-
Gazi UniversityCompleted
-
Associacao de Investigacao de Cuidados de Suporte...Universidad Europea de Madrid; Centro Hospitalar de Vila Nova de Gaia/Espinho; University Institute of MaiaCompletedBreast CancerPortugal
-
Federal University of UberlandiaCompletedMenopause | Exercise | Blood Pressure, HighBrazil
-
Pusan National UniversityDong-Eui UniversityCompleted
-
Ankara Yildirim Beyazıt UniversityCompletedPhysical TherapyTurkey
-
University of AthensUnknown
-
Riphah International UniversityCompletedHypertension | ObesePakistan
-
Gazi UniversityActive, not recruiting
-
Bezmialem Vakif UniversityCompletedMultiple Sclerosis, Relapsing-Remitting
-
University of BarcelonaUniversity of Pittsburgh; Germans Trias i Pujol Hospital; Ministerio de Economía... and other collaboratorsCompletedAging | Cognitive Function 1, SocialSpain